These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17715336)

  • 21. The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes.
    Woodman B; Butler R; Landles C; Lupton MK; Tse J; Hockly E; Moffitt H; Sathasivam K; Bates GP
    Brain Res Bull; 2007 Apr; 72(2-3):83-97. PubMed ID: 17352931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered Aconitase 2 Activity in Huntington's Disease Peripheral Blood Cells and Mouse Model Striatum.
    Chen CM; Wu YR; Chang KH
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.
    Jin J; Peng Q; Hou Z; Jiang M; Wang X; Langseth AJ; Tao M; Barker PB; Mori S; Bergles DE; Ross CA; Detloff PJ; Zhang J; Duan W
    Hum Mol Genet; 2015 May; 24(9):2508-27. PubMed ID: 25609071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG
    Stefanko DP; Shah VD; Yamasaki WK; Petzinger GM; Jakowec MW
    Neurobiol Dis; 2017 Sep; 105():15-32. PubMed ID: 28502806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice.
    Fossale E; Wheeler VC; Vrbanac V; Lebel LA; Teed A; Mysore JS; Gusella JF; MacDonald ME; Persichetti F
    Hum Mol Genet; 2002 Sep; 11(19):2233-41. PubMed ID: 12217951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes.
    Dragileva E; Hendricks A; Teed A; Gillis T; Lopez ET; Friedberg EC; Kucherlapati R; Edelmann W; Lunetta KL; MacDonald ME; Wheeler VC
    Neurobiol Dis; 2009 Jan; 33(1):37-47. PubMed ID: 18930147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington disease.
    Höhn S; Dallérac G; Faure A; Urbach YK; Nguyen HP; Riess O; von Hörsten S; Le Blanc P; Desvignes N; El Massioui N; Brown BL; Doyère V
    J Neurosci; 2011 Jun; 31(24):8986-97. PubMed ID: 21677182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
    Menalled LB; Kudwa AE; Miller S; Fitzpatrick J; Watson-Johnson J; Keating N; Ruiz M; Mushlin R; Alosio W; McConnell K; Connor D; Murphy C; Oakeshott S; Kwan M; Beltran J; Ghavami A; Brunner D; Park LC; Ramboz S; Howland D
    PLoS One; 2012; 7(12):e49838. PubMed ID: 23284626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.
    Hickey MA; Kosmalska A; Enayati J; Cohen R; Zeitlin S; Levine MS; Chesselet MF
    Neuroscience; 2008 Nov; 157(1):280-95. PubMed ID: 18805465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse.
    Wheeler VC; Auerbach W; White JK; Srinidhi J; Auerbach A; Ryan A; Duyao MP; Vrbanac V; Weaver M; Gusella JF; Joyner AL; MacDonald ME
    Hum Mol Genet; 1999 Jan; 8(1):115-22. PubMed ID: 9887339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal analysis of the behavioural phenotype in HdhQ92 Huntington's disease knock-in mice.
    Brooks S; Higgs G; Jones L; Dunnett SB
    Brain Res Bull; 2012 Jun; 88(2-3):148-55. PubMed ID: 20457229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
    Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's disease mice: genome-wide and candidate approaches.
    Pinto RM; Dragileva E; Kirby A; Lloret A; Lopez E; St Claire J; Panigrahi GB; Hou C; Holloway K; Gillis T; Guide JR; Cohen PE; Li GM; Pearson CE; Daly MJ; Wheeler VC
    PLoS Genet; 2013 Oct; 9(10):e1003930. PubMed ID: 24204323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
    Spires TL; Grote HE; Garry S; Cordery PM; Van Dellen A; Blakemore C; Hannan AJ
    Eur J Neurosci; 2004 May; 19(10):2799-807. PubMed ID: 15147313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Light and electron microscopic characterization of the evolution of cellular pathology in the Hdh(CAG)150 Huntington's disease knock-in mouse.
    Bayram-Weston Z; Torres EM; Jones L; Dunnett SB; Brooks SP
    Brain Res Bull; 2012 Jun; 88(2-3):189-98. PubMed ID: 21511013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington's disease CAG knock-in mice across multiple genetic backgrounds.
    Ament SA; Pearl JR; Grindeland A; St Claire J; Earls JC; Kovalenko M; Gillis T; Mysore J; Gusella JF; Lee JM; Kwak S; Howland D; Lee MY; Baxter D; Scherler K; Wang K; Geman D; Carroll JB; MacDonald ME; Carlson G; Wheeler VC; Price ND; Hood LE
    Hum Mol Genet; 2017 Mar; 26(5):913-922. PubMed ID: 28334820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of TDP-43 promotes somatic CAG repeat expansion in Huntington's disease knock-in mice.
    Bai D; Zhu L; Jia Q; Duan X; Chen L; Wang X; Hou J; Jiang G; Yang S; Li S; Li XJ; Yin P
    Prog Neurobiol; 2023 Aug; 227():102484. PubMed ID: 37315918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Neurodegeneration in R6/2 Mice Carrying the Huntington's Disease Mutation with a Super-Expanded CAG Repeat, Despite Normal Lifespan.
    Kielar C; Morton AJ
    J Huntingtons Dis; 2018; 7(1):61-76. PubMed ID: 29480204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease.
    Sebastianutto I; Cenci MA; Fieblinger T
    Neurobiol Dis; 2017 Sep; 105():117-131. PubMed ID: 28578004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.